Minerva neurosciences, inc. (NERV)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Sep'13Jun'13
Expenses
Research and development

8,082

28,524

9,674

8,319

11,606

9,007

8,369

9,062

8,449

6,540

8,956

7,144

7,614

6,498

5,852

2,714

5,374

6,259

3,828

4,484

3,961

3,030

24,737

14,554

585

190

249

General and administrative

4,189

3,843

4,607

4,584

4,705

4,619

4,054

3,872

4,294

2,991

2,450

2,601

2,870

2,738

2,379

2,250

2,382

1,934

1,876

1,847

1,917

4,415

2,413

3,095

2,037

291

128

Total expenses

12,271

32,367

14,281

12,903

16,311

13,627

12,424

12,934

12,743

9,532

11,407

9,745

10,485

9,237

8,231

4,964

7,756

8,194

5,704

6,332

5,878

7,445

27,151

17,649

2,623

482

378

Loss from operations

-12,271

-32,367

-14,281

-12,903

-16,311

-13,627

-12,424

-12,934

-12,743

-9,532

-11,407

-9,745

-10,485

-9,237

-8,231

-4,964

-7,756

-8,194

-5,704

-6,332

-5,878

-7,445

-27,151

-17,649

-2,623

-482

-378

Foreign exchange losses

-9

-10

-4

-6

-6

-5

-10

29

-18

-10

-9

-20

-16

4

-2

-15

-9

-0

-2

-29

15

3

10

10

-6

-2

-

Investment income

129

206

324

434

490

429

418

411

414

433

293

155

58

61

69

34

32

-

37

27

-

-

-

-

-

-

2

Interest expense

-

-

-

-

-

0

-4

-35

-70

-104

-137

-170

-201

-232

-258

-268

-270

-276

-269

-275

-230

-

-14

-1,726

-

-

-

Net loss

-12,151

-29,917

-13,962

-12,476

-15,827

-13,202

-12,020

-12,529

-12,418

162

-11,260

-9,780

-10,644

-9,404

-8,423

-5,213

-8,004

-8,439

-5,939

-6,610

-6,093

-

-27,155

-19,365

-

-

-

Interest (expense) income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-308

-2

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,938

-488

-375

Net loss per share, basic and diluted

-0.31

-0.76

-0.36

-0.32

-0.41

-0.34

-0.31

-0.32

-0.32

0.02

-0.28

-0.27

-0.30

-0.28

-0.24

-0.18

-0.29

-0.34

-0.24

-0.27

-0.31

0.04

-1.53

-2.55

-0.43

-0.12

-0.10

Weighted average shares outstanding, basic and diluted

39,177

39,038

39,025

39,025

38,968

38,889

38,781

38,749

38,749

38,779

40,880

36,719

35,369

34,925

34,806

29,122

27,202

24,789

24,721

24,721

19,416

18,637

17,752

7,604

6,902

4,091

3,916